+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Liquid Biopsy Market - Global Forecast 2026-2032- Product Image
Canine Liquid Biopsy Market - Global Forecast 2026-2032- Product Image
Sale

Canine Liquid Biopsy Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6151019
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Liquid Biopsy Market is projected to reach USD 172.56 Million in 2026. It is expected to continue growing at a CAGR of 9.10%, reaching USD 290.21 Million by 2032.

Canine Liquid Biopsy: Executive Summary and Strategic Context

Canine liquid biopsy uses blood or other bodily fluids to identify cancer-associated signals, including circulating tumor DNA, circulating tumor cells, extracellular vesicles, and molecular biomarkers. In veterinary medicine, its value lies in supporting less invasive diagnosis, disease characterization, treatment selection, and monitoring while complementing imaging, cytology, histopathology, and clinical assessment. Adoption depends on analytical validity, sample quality, turnaround time, veterinary workflow integration, and evidence that test results improve clinical decisions and animal outcomes.

Clinical Workflows Are Shifting Toward Less Invasive Molecular Monitoring

The landscape is moving from episodic tissue-based assessment toward integrated diagnostic pathways that combine liquid samples with imaging and conventional pathology. This shift is especially relevant when tumors are difficult to access, tissue is limited, repeated sampling is needed, or disease may be heterogeneous. Key priorities include standardized pre-analytical procedures, validated assays for canine biology, clear interpretation frameworks, and prospective clinical studies linking biomarkers with diagnosis, prognosis, treatment response, and recurrence monitoring.

Artificial Intelligence Strengthens Signal Detection and Clinical Integration

Artificial intelligence can support canine liquid biopsy by identifying molecular patterns in sequencing, methylation, proteomic, and image-linked datasets; improving quality control; and integrating laboratory findings with clinical records. Its practical contribution depends on representative training data, external validation across breeds and disease stages, transparent performance reporting, and safeguards against false positives caused by inflammation, age-related changes, or technical artifacts. AI should augment veterinary judgment rather than replace confirmatory diagnostics or informed clinical decision-making.

Regional Insights: Infrastructure and Evidence Standards Shape Adoption

North America benefits from comparatively developed veterinary specialty networks, research capacity, and access to advanced diagnostics, while Latin America is likely to require scalable workflows, cost-conscious testing, and expanded laboratory access. Europe places strong emphasis on evidence quality, animal welfare, data governance, and cross-border standardization. The Middle East presents opportunities through expanding referral and specialty-care infrastructure, whereas Africa may prioritize mobile sampling, regional laboratory hubs, and affordability. Asia-Pacific combines advanced capabilities in selected markets with substantial variation in access, creating demand for adaptable platforms and locally validated evidence.

Group Insights: Economic and Regulatory Networks Create Different Entry Conditions

ASEAN markets may benefit from shared laboratory capacity and regional partnerships, but differences in veterinary infrastructure and regulation require localized implementation. BRICS countries offer diverse research, clinical, and manufacturing capabilities, alongside uneven access and regulatory pathways. The European Union supports collaborative evidence generation and harmonized approaches within a structured regulatory environment. G7 markets generally provide strong academic, specialty-care, and data capabilities, while NATO countries may benefit from interconnected research and institutional networks. GCC markets can leverage concentrated specialty-care investment and referral infrastructure, with attention to local clinical validation and workforce development.

Country Insights: National Capacity Determines Clinical Deployment Priorities

Australia and Canada can build on specialist veterinary services, research institutions, and geographically dispersed care models. Brazil, Mexico, India, and South Africa require approaches that address uneven laboratory access, affordability, and regional referral patterns. China, Japan, and South Korea have substantial diagnostic, biotechnology, and clinical research capabilities, but deployment must reflect national regulatory and data environments. France, Germany, Italy, Spain, and the United Kingdom can support adoption through established veterinary and biomedical research ecosystems, with continued emphasis on validation and quality standards. Russia presents a distinct regulatory and infrastructure context requiring locally appropriate evidence and supply arrangements. Across all countries, breed diversity, disease prevalence, reimbursement, sample transport, and clinician training are central implementation considerations.

Action Priorities for Leaders Building Reliable Canine Liquid Biopsy Programs

Industry leaders should first define high-value clinical use cases, such as triage, recurrence monitoring, or treatment-response assessment, before expanding into broad screening claims. They should invest in multicenter prospective validation, standardized collection and processing protocols, reference materials, and transparent reporting of sensitivity, specificity, repeatability, and limitations. Partnerships with veterinary hospitals and diagnostic laboratories can improve workflow fit and longitudinal data quality. Commercial plans should include clinician education, clear result interpretation, secure data practices, and pricing models aligned with owner decision-making and veterinary practice realities. AI-enabled products should undergo independent performance testing and continuous post-deployment monitoring.

Research Methodology: Evidence-Led Assessment of a Developing Diagnostic Field

This executive summary applies a structured qualitative review of the canine liquid biopsy field, organizing findings around clinical use cases, assay development, laboratory workflows, artificial intelligence, regional conditions, and national implementation factors. The assessment distinguishes established diagnostic principles from emerging applications and avoids unsupported claims about commercial scale. Interpretation should be updated as peer-reviewed validation studies, regulatory guidance, veterinary consensus standards, and real-world outcome data become available. Comparisons across geographies consider infrastructure, research capacity, regulation, affordability, and access rather than assuming uniform readiness.

Conclusion: Validation and Workflow Fit Will Define Sustainable Progress

Canine liquid biopsy has the potential to make cancer assessment more repeatable, minimally invasive, and molecularly informed, but meaningful clinical value depends on rigorous validation and appropriate integration with existing diagnostics. Regional and national differences will shape adoption pathways, while AI may improve analytical efficiency when supported by robust data and transparent oversight. Leaders that prioritize clinically relevant applications, standardized operations, evidence generation, and veterinary usability will be best positioned to translate technical advances into dependable care for dogs and informed decisions for their owners.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Canine Liquid Biopsy Market, by Sample Type
7.1. Introduction
7.2. Plasma
7.3. Serum
7.4. Whole Blood
8. Canine Liquid Biopsy Market, by Technology
8.1. Introduction
8.2. Microarray
8.3. NGS
8.3.1. Targeted Sequencing
8.3.2. Wgs
8.4. PCR
8.4.1. Ddpcr
8.4.2. Qpcr
9. Canine Liquid Biopsy Market, by Application
9.1. Introduction
9.2. Infectious Disease
9.2.1. Bacterial
9.2.2. Viral
9.3. Oncology
9.3.1. Early Detection
9.3.2. Monitoring
10. Canine Liquid Biopsy Market, by End User
10.1. Introduction
10.2. Point Of Care Diagnostics
10.3. Reference Laboratories
10.4. Research Institutes
10.5. Veterinary Hospitals
11. Canine Liquid Biopsy Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Canine Liquid Biopsy Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Canine Liquid Biopsy Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Antech Diagnostics
15.2. Bio-Rad Laboratories, Inc.
15.3. CanCan Diagnostics
15.4. Heska Corporation
15.5. IDEXX Laboratories, Inc.
15.6. Mars, Incorporated
15.7. Neogen Corporation
15.8. PerkinElmer, Inc.
15.9. PetDx
15.10. QIAGEN N.V.
15.11. Thermo Fisher Scientific Inc.
15.12. VCA Animal Health, Inc.
15.13. Vidium Animal Health
15.14. Volition
15.15. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Canine Liquid Biopsy Market, Years Considered for the Study
FIGURE 2. Global Canine Liquid Biopsy Market, Research Design
FIGURE 3. Global Canine Liquid Biopsy Market, Research Framework
FIGURE 4. Global Canine Liquid Biopsy Market, Data Triangulation
FIGURE 5. Global Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Canine Liquid Biopsy Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 7. Global Canine Liquid Biopsy Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Canine Liquid Biopsy Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Canine Liquid Biopsy Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Canine Liquid Biopsy Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Canine Liquid Biopsy Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Canine Liquid Biopsy Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Canine Liquid Biopsy Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Canine Liquid Biopsy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Canine Liquid Biopsy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Canine Liquid Biopsy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Canine Liquid Biopsy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Canine Liquid Biopsy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Canine Liquid Biopsy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Canine Liquid Biopsy Market Segmentation & Coverage
TABLE 2. Global Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 4. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 14. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global NGS Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global NGS Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global NGS Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Wgs Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Wgs Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Wgs Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Ddpcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Ddpcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Ddpcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Qpcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Qpcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Qpcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 36. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Early Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Early Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Early Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Point Of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Point Of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Point Of Care Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. North America Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. North America Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 79. North America Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. North America Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 81. North America Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 82. North America Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. North America Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 84. North America Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 85. North America Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Latin America Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Latin America Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 88. Latin America Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Latin America Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 90. Latin America Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 91. Latin America Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Latin America Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 93. Latin America Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 94. Latin America Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Europe Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Europe Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 97. Europe Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 98. Europe Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 99. Europe Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 100. Europe Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Europe Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 102. Europe Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 103. Europe Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Middle East Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Middle East Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 106. Middle East Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Middle East Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 108. Middle East Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 109. Middle East Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Middle East Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 111. Middle East Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 112. Middle East Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Africa Canine Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 115. Africa Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. Africa Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 117. Africa Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 118. Africa Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Africa Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 120. Africa Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 121. Africa Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Global Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 125. ASEAN Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 126. ASEAN Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 127. ASEAN Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 128. ASEAN Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. ASEAN Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 130. ASEAN Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 131. ASEAN Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. GCC Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. GCC Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 134. GCC Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. GCC Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 136. GCC Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 137. GCC Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. GCC Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 139. GCC Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 140. GCC Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. European Union Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. European Union Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 143. European Union Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. European Union Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 145. European Union Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 146. European Union Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. European Union Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 148. European Union Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 149. European Union Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. BRICS Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. BRICS Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. BRICS Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. BRICS Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 154. BRICS Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 155. BRICS Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. BRICS Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 157. BRICS Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 158. BRICS Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. G7 Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 161. G7 Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 162. G7 Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 163. G7 Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 164. G7 Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. G7 Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 166. G7 Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 167. G7 Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. NATO Canine Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. NATO Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. NATO Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. NATO Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 172. NATO Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 173. NATO Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. NATO Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 175. NATO Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 176. NATO Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Global Canine Liquid Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. United States Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 179. United States Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 180. United States Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. United States Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 182. United States Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 183. United States Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. United States Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 185. United States Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 186. United States Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Canada Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 188. Canada Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. Canada Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. Canada Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 191. Canada Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 192. Canada Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Canada Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 194. Canada Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 195. Canada Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Mexico Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 197. Mexico Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 198. Mexico Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. Mexico Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 200. Mexico Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 201. Mexico Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Mexico Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 203. Mexico Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 204. Mexico Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Brazil Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 206. Brazil Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 207. Brazil Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Brazil Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 209. Brazil Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 210. Brazil Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Brazil Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 212. Brazil Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 213. Brazil Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. United Kingdom Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 215. United Kingdom Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. United Kingdom Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. United Kingdom Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 218. United Kingdom Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 219. United Kingdom Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. United Kingdom Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 221. United Kingdom Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 222. United Kingdom Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Germany Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 224. Germany Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 225. Germany Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Germany Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 227. Germany Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 228. Germany Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Germany Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 230. Germany Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 231. Germany Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. France Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 233. France Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 234. France Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. France Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 236. France Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 237. France Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. France Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 239. France Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 240. France Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Russia Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 242. Russia Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 243. Russia Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. Russia Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 245. Russia Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 246. Russia Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. Russia Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 248. Russia Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 249. Russia Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Italy Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 251. Italy Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 252. Italy Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. Italy Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 254. Italy Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 255. Italy Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Italy Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 257. Italy Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 258. Italy Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Spain Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 260. Spain Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 261. Spain Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 262. Spain Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 263. Spain Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 264. Spain Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. Spain Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 266. Spain Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 267. Spain Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. China Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 269. China Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 270. China Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. China Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 272. China Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 273. China Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. China Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 275. China Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 276. China Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. India Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 278. India Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 279. India Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. India Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 281. India Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 282. India Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. India Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 284. India Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 285. India Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Japan Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 287. Japan Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 288. Japan Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. Japan Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 290. Japan Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 291. Japan Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Japan Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 293. Japan Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 294. Japan Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Australia Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 296. Australia Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 297. Australia Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 298. Australia Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 299. Australia Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 300. Australia Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. Australia Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 302. Australia Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 303. Australia Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. South Korea Canine Liquid Biopsy Market Size, 2017-2032 (USD Million)
TABLE 305. South Korea Canine Liquid Biopsy Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 306. South Korea Canine Liquid Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 307. South Korea Canine Liquid Biopsy Market Size, by NGS, 2017-2032 (USD Million)
TABLE 308. South Korea Canine Liquid Biopsy Market Size, by PCR, 2017-2032 (USD Million)
TABLE 309. South Korea Canine Liquid Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. South Korea Canine Liquid Biopsy Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 311. South Korea Canine Liquid Biopsy Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 312. South Korea Canine Liquid Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Global Canine Liquid Biopsy Market Share, by Key Player, 2025
TABLE 314. Global Canine Liquid Biopsy Market, Key Experts

Companies Mentioned

  • Antech Diagnostics
  • Bio-Rad Laboratories, Inc.
  • CanCan Diagnostics
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Mars, Incorporated
  • Neogen Corporation
  • PerkinElmer, Inc.
  • PetDx
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • VCA Animal Health, Inc.
  • Vidium Animal Health
  • Volition
  • Zoetis Inc.

Related Topics

Related Reports

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Liquid Biopsy Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Breast Cancer Liquid Biopsy - Global Strategic Business Report - Product Image

Breast Cancer Liquid Biopsy - Global Strategic Business Report

  • Report
  • 217 Pages
  • Global
From
Non-Cancer Liquid Biopsy Testing Market - A Global and Regional Analysis: Focus on Application, Technology, End User, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Non-Cancer Liquid Biopsy Testing Market - A Global and Regional Analysis: Focus on Application, Technology, End User, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • 146 Pages
  • Global
From
?Breast Cancer Liquid Biopsy Market Report by Product Service, Circulating Biomaker, End User, and Region 2026-2034 - Product Image

?Breast Cancer Liquid Biopsy Market Report by Product Service, Circulating Biomaker, End User, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.